Browsing Ciències de la Salut by Author "Niubó, Jordi"
Now showing items 1-2 of 2
-
Methylprednisolone pulses plus tacrolimus in addition to standard of care vs. standard of care alone in patients with severe COVID-19. A randomized controlled trial
Solanich, Xavier; Antolí, Arnau; Rocamora-Blanch, Gemma; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Riera-Mestre, Antoni; Bas, Jordi; Vicens-Zygmunt, Vanesa; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Mensa-Vilaró, Anna; Arregui, Laura; Tebé, Cristian; Videla, Sebastià; Hereu, Pilar; Corbella Virós, Xavier (Frontiers in Medicine, 2021)Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, ... -
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
Solanich, Xavier; Antolí, Arnau; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Molina, M.; Sabater-Riera, Joan; Bas, Jordi; Mensa-Vilaró, Anna; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Arregui, Laura; Tebé, Cristian; Hereu, Pilar; Videla, S.; Corbella Virós, Xavier (Contemporary Clinical Trials Communications, 2021-03)Introduction: Some COVID-19 patients evolve to severe lung injury and systemic hyperinflammatory syndrome triggered by both the coronavirus infection and the subsequent host-immune response. Accordingly, ...